pith. sign in

Tim Friede

Identifiers

  • name variant Tim Friede 0.60 · backfill

Papers (22)

  1. Subgroup analysis in randomized controlled trials with binary outcomes: dilution and logic-respecting properties stat.ME · 2026 · author #3
  2. Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials stat.AP · 2019 · author #5
  3. Seamless phase II/III clinical trials using early outcomes for treatment or subgroup selection: Methods and aspects of their implementation stat.ME · 2019 · author #1
  4. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?": A Bayesian perspective stat.ME · 2018 · author #2
  5. Likelihood-based meta-analysis with few studies: Empirical and simulation studies stat.ME · 2018 · author #3
  6. Model averaging for robust extrapolation in evidence synthesis stat.ME · 2018 · author #3
  7. On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies stat.OT · 2018 · author #17
  8. Group sequential designs for negative binomial outcomes stat.AP · 2017 · author #4
  9. Sample size re-estimation incorporating prior information on a nuisance parameter stat.AP · 2017 · author #3
  10. Blinded sample size re-estimation in three-arm trials with 'gold standard' design stat.AP · 2016 · author #2
  11. A studentized permutation test for three-arm trials in the 'gold standard' design stat.AP · 2016 · author #4
  12. Gender differences in appropriate shocks and mortality among patients with primary prophylactic implantable cardioverter-defibrillators: Systematic review and meta-analysis physics.med-ph · 2016 · author #9
  13. Using phase II data for the analysis of phase III studies: an application in rare diseases stat.ME · 2016 · author #3
  14. Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases stat.ME · 2016 · author #1
  15. Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions q-bio.QM · 2016 · author #7
  16. Discrete approximation of a mixture distribution via restricted divergence stat.CO · 2016 · author #2
  17. Meta-analysis of few small studies in orphan diseases stat.ME · 2016 · author #1
  18. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies stat.ME · 2015 · author #3
  19. Interleukin-2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta-analysis of controlled studies q-bio.QM · 2014 · author #4
  20. Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data stat.ME · 2013 · author #3
  21. Changing EDSS progression in placebo cohorts in relapsing MS: A systematic review and meta-regression stat.AP · 2013 · author #4
  22. Explaining temporal trends in annualized relapse rates in placebo groups of randomized controlled trials in relapsing multiple sclerosis: systematic review and meta-regression stat.AP · 2013 · author #6

Mentions

  • 2606.17841 #3 · arxiv_oai · confidence 0.70 Tim Friede
  • 1508.01227 #3 · backfill · confidence 0.70 Tim Friede
  • 1402.2643 #4 · backfill · confidence 0.70 Tim Friede
  • 1312.3958 #3 · backfill · confidence 0.70 Tim Friede
  • 1308.4827 #4 · backfill · confidence 0.70 Tim Friede
  • 1303.2803 #6 · backfill · confidence 0.70 Tim Friede

Frequent Coauthors